MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 26, 2004; DOI: 10.1124/mol.104.000554


0026-895X/04/6603-492-501$20.00
Mol Pharmacol 66:492-501, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.000554v1
66/3/492    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.

3-Morpholinylsydnonimine Inhibits Glutamatergic Transmission in Rat Rostral Ventrolateral Medulla via Peroxynitrite Formation and Adenosine Release

Chiung-Chun Huang, Samuel H. H. Chan, and Kuei-Sen Hsu

Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan (C.-C.H., K.-S.H.); and Center for Neuroscience, National Sun Yat-sen University, Kaohsiung, Taiwan (S.H.H.C.)

We have previously reported that, depending on the dose, nitric oxide (NO)-generating agents exert a dual facilitatory and inhibitory action on glutamatergic transmission on the rostral ventrolateral medulla (RVLM) neurons. The molecular mechanisms underlying the NO-mediated synaptic inhibition have not yet been defined. Here we show that the amplitude of excitatory postsynaptic currents (EPSCs) was reversibly reduced by the NO donors 3-morpholinylsydnoneimine (SIN-1) (1 mM) and spermine NONOate (1 mM). This effect was antagonized by an active peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl)prophyrinato iron (III) chloride, Gi/o-coupled receptor blockers, N-ethylmaleimide and pertussis toxin, A1 adenosine receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine, or adenosine deaminase. However, NO-sensitive guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, GABAB receptor antagonist (2S)-(+)-5,5-dimethyl-2-morpholineacetic acid (SCH50911, or cannabinoid receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR141716A) had no effect on the inhibitory action of SIN-1 on EPSCs. Perfusion of adenosine mimicked and subsequently occluded the action of SIN-1. Inhibition of EPSC amplitude by SIN-1 was associated with an increase in the paired-pulse ratio of EPSCs. Furthermore, SIN reduced the frequency of spontaneous EPSCs without altering their amplitude of distribution. Pretreatment with N-type Ca2+-channel blocker {omega}-conotoxin GVIA selectively blocked SIN-1–induced inhibition of EPSCs. These results suggest that a higher dose of SIN-1 acts presynaptically to elicit a synaptic depression on the RVLM neurons through an inhibition of presynaptic N-type Ca2+-channel activity, leading to reduced glutamate release. The presynaptic action of SIN-1 is mediated by the formation of peroxynitrite, which subsequently acts to release adenosine to activate A1 adenosine receptors.


Received March 16, 2004; accepted May 24, 2004

Address correspondence to: Dr. Kuei-Sen Hsu, Department of Pharmacology, College of Medicine, National Cheng Kung University, 1, Ta-Hsiue Road, Tainan 701, Taiwan. E-mail: richard{at}mail.ncku.edu.tw




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Wang, T. A. Milner, R. C. Speth, A. C. Gore, D. Wu, C. Iadecola, and J. P. Pierce
Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1149 - R1157.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Yang and C. L. Cox
Excitatory and anti-oscillatory actions of nitric oxide in thalamus
J. Physiol., August 1, 2008; 586(15): 3617 - 3628.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Y. H. Chan, C. H. Y. Wu, C.-Y. Tsai, H.-L. Cheng, K.-Y. Dai, S. H. H. Chan, and A. Y. W. Chang
Transcriptional up-regulation of nitric oxide synthase II by nuclear factor-{kappa}B at rostral ventrolateral medulla in a rat mevinphos intoxication model of brain stem death
J. Physiol., June 15, 2007; 581(3): 1293 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Y. H. Chan, H.-L. Cheng, J. L. J. Chou, F. C. H. Li, K.-Y. Dai, S. H. H. Chan, and A. Y. W. Chang
Heat Shock Protein 60 or 70 Activates Nitric-oxide Synthase (NOS) I- and Inhibits NOS II-associated Signaling and Depresses the Mitochondrial Apoptotic Cascade during Brain Stem Death
J. Biol. Chem., February 16, 2007; 282(7): 4585 - 4600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. C. H. Li, J. Y. H. Chan, S. H. H. Chan, and A. Y. W. Chang
In the Rostral Ventrolateral Medulla, the 70-kDa Heat Shock Protein (HSP70), but Not HSP90, Confers Neuroprotection against Fatal Endotoxemia via Augmentation of Nitric-Oxide Synthase I (NOS I)/Protein Kinase G Signaling Pathway and Inhibition of NOS II/Peroxynitrite Cascade
Mol. Pharmacol., July 1, 2005; 68(1): 179 - 192.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics